- Home
- CERO vs POLA Comparison
CERO vs POLA Comparison
Compare CERO & POLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERO
- POLA
- Stock Information
- Founded
- CERO 2017
- POLA 1979
- Country
- CERO United States
- POLA United States
- Employees
- CERO N/A
- POLA N/A
- Industry
- CERO
- POLA Industrial Machinery/Components
- Sector
- CERO
- POLA Miscellaneous
- Exchange
- CERO Nasdaq
- POLA Nasdaq
- Market Cap
- CERO 3.5M
- POLA 4.3M
- IPO Year
- CERO N/A
- POLA 2016
- Fundamental
- Price
- CERO $8.90
- POLA $1.91
- Analyst Decision
- CERO Strong Buy
- POLA
- Analyst Count
- CERO 2
- POLA 0
- Target Price
- CERO $45.00
- POLA N/A
- AVG Volume (30 Days)
- CERO 3.3M
- POLA 278.0K
- Earning Date
- CERO 08-13-2025
- POLA 08-13-2025
- Dividend Yield
- CERO N/A
- POLA N/A
- EPS Growth
- CERO N/A
- POLA N/A
- EPS
- CERO N/A
- POLA N/A
- Revenue
- CERO N/A
- POLA $13,918,000.00
- Revenue This Year
- CERO N/A
- POLA N/A
- Revenue Next Year
- CERO N/A
- POLA N/A
- P/E Ratio
- CERO N/A
- POLA N/A
- Revenue Growth
- CERO N/A
- POLA 8.08
- 52 Week Low
- CERO $6.71
- POLA $1.53
- 52 Week High
- CERO $895.40
- POLA $4.90
- Technical
- Relative Strength Index (RSI)
- CERO 46.23
- POLA 62.97
- Support Level
- CERO $8.50
- POLA $1.82
- Resistance Level
- CERO $9.73
- POLA $1.97
- Average True Range (ATR)
- CERO 1.20
- POLA 0.16
- MACD
- CERO -0.01
- POLA 0.03
- Stochastic Oscillator
- CERO 14.54
- POLA 33.70
About CERO CERo Therapeutics Holdings Inc. Common Stock
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.
About POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.